Template:Lipoprotein disorders: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''Hyperlipidemia Microchapters
'''Lipoprotein disorders Microchapters
'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 10: Line 10:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Hyperlipidemia|Home]]
[[Lipoprotein disorders|Home]]
|-  
|-  
!
!
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia (patient information)|Patient Information]]
[[Lipoprotein disorders (patient information)|Patient Information]]
|-  
|-  
!
!
Line 22: Line 22:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia overview|Overview]]
[[Lipoprotein disorders overview|Overview]]
|-  
|-  
!
!
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia classification|Classification]]
[[Lipoprotein disorders classification|Classification]]
|-  
|-  
!
!
Line 34: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia pathophysiology|Pathophysiology]]
[[Lipoprotein disorders pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia causes|Causes]]
[[Lipoprotein disorders causes|Causes]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia differential diagnosis|Differentiating Hyperlipidemia from other Diseases]]
[[Lipoprotein disorders differential diagnosis|Differentiating Lipoprotein disorders from other Diseases]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia epidemiology and demographics|Epidemiology and Demographics]]
[[Lipoprotein disorders epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia risk factors|Risk Factors]]
[[Lipoprotein disorders risk factors|Risk Factors]]
|-  
|-  
!
!
Line 64: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia screening|Screening]]
[[Lipoprotein disorders screening|Screening]]
|-  
|-  
!
!
Line 70: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipidemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]
[[Lipoprotein disorders natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 82: Line 82:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Hyperlipidemia history and symptoms|History and Symptoms]]
[[Lipoprotein disorders history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 88: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Hyperlipidemia physical examination|Physical Examination]]
[[Lipoprotein disorders physical examination|Physical Examination]]
|-  
|-  
!
!
Line 94: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Hyperlipidemia laboratory findings|Laboratory Findings]]
[[Lipoprotein disorders laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 106:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipidemia medical therapy|Medical Therapy]]
[[Lipoprotein disorders medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 112: Line 112:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipidemia prevention| Prevention]]
[[Lipoprotein disorders prevention| Prevention]]
|-  
|-  
!  
!  
Line 118: Line 118:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipidemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Lipoprotein disorders cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!
!
Line 124: Line 124:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipidemia future or investigational therapies|Future or Investigational Therapies]]
[[Lipoprotein disorders future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!
!
Line 135: Line 135:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipidemia case study one|Case #1]]
[[Lipoprotein disorders case study one|Case #1]]
|-  
|-  
!
!
Line 235: Line 235:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Hyperlipidemia}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Hyperlipidemia]
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Lipoprotein disorders}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Lipoprotein disorders]
|-  
|-  
!  
!  

Revision as of 14:02, 12 September 2013

Lipoprotein disorders Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Lipoprotein disorders from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoprotein disorders On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoprotein disorders

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoprotein disorders

CDC on Lipoprotein disorders

Lipoprotein disorders in the news

Blogs on Lipoprotein disorders

Directions to Hospitals Treating Lipoprotein disorders

Risk calculators and risk factors for Lipoprotein disorders

Retrieved from "https://www.wikidoc.org/index.php?title=Template:Lipoprotein_disorders&oldid=904384"